Literature DB >> 35411068

Genetically engineered CAR T cells to hack prostate cancer TME.

Maria Chiara Masone1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35411068     DOI: 10.1038/s41585-022-00599-w

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.

Authors:  In-Young Jung; Simon F Lacey; Andrew J Rech; Megan M Davis; Carl H June; Joseph A Fraietta; Naomi B Haas; Vivek Narayan; Julie S Barber-Rotenberg; Wei-Ting Hwang; Priti Lal; Erica L Carpenter; Shannon L Maude; Gabriela Plesa; Neha Vapiwala; Anne Chew; Michael Moniak; Ronnie A Sebro; Michael D Farwell; Amy Marshall; Joan Gilmore; Lester Lledo; Karen Dengel; Sarah E Church; Tyler D Hether; Jun Xu; Mercy Gohil; Thomas H Buckingham; Stephanie S Yee; Vanessa E Gonzalez; Irina Kulikovskaya; Fang Chen; Lifeng Tian; Kyle Tien; Whitney Gladney; Christopher L Nobles; Hayley E Raymond; Elizabeth O Hexner; Donald L Siegel; Frederic D Bushman
Journal:  Nat Med       Date:  2022-03-21       Impact factor: 87.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.